Altogether, observations of retinal atrophy in layers recognized as sites of proteinaceous deposition in both AD patients and animal models of the disease illustrate the vulnerability of retinal cell types to pathological processes traditionally associated with the cerebral disease. In addition, these findings further support the suitability of retinal thinning, in combination with more specific markers, as a diagnostic and monitoring tool for AD.